<code id='6789D0E3E1'></code><style id='6789D0E3E1'></style>
    • <acronym id='6789D0E3E1'></acronym>
      <center id='6789D0E3E1'><center id='6789D0E3E1'><tfoot id='6789D0E3E1'></tfoot></center><abbr id='6789D0E3E1'><dir id='6789D0E3E1'><tfoot id='6789D0E3E1'></tfoot><noframes id='6789D0E3E1'>

    • <optgroup id='6789D0E3E1'><strike id='6789D0E3E1'><sup id='6789D0E3E1'></sup></strike><code id='6789D0E3E1'></code></optgroup>
        1. <b id='6789D0E3E1'><label id='6789D0E3E1'><select id='6789D0E3E1'><dt id='6789D0E3E1'><span id='6789D0E3E1'></span></dt></select></label></b><u id='6789D0E3E1'></u>
          <i id='6789D0E3E1'><strike id='6789D0E3E1'><tt id='6789D0E3E1'><pre id='6789D0E3E1'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:772
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex
          Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

          IsnoonesafefromtheFTC?HasPfizerbottomedout?Andisbiotechfinallyback?Wecoverallthatandmorethisweekon“T

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Lilly's Alzheimer's drug donanemab backed by FDA advisers

          DarronCummings/APAdviserstotheFoodandDrugAdministrationvoted11-0onMondaytorecommendtheapprovalofadru